Bioinformatics Market Size and Share: A Decade of Remarkable Growth
The global bioinformatics market has witnessed unprecedented growth over the past decade, fueled by various factors such as advancements in next-generation sequencing technologies, increased demand for software development, and expanding applications in the biological sciences. A recent report reveals that there are now more than 300 active startup companies in this sector, with prominent corporations like IBM Corp., Novartis AG, and GE Healthcare investing heavily in these startups. Life science startups have surged, now representing a staggering 60% of all biotech companies worldwide.
The burgeoning bioinformatics market is also seeing traditional pharmaceutical organizations eager to acquire early-stage technology firms to diversify their product pipelines and discover new drug targets. Clinical research organizations (CROs) are offering bioinformatics services for consulting and biomarker assay validation, reflecting their growing involvement in clinical trials. Additionally, the proliferation of diagnostic companies offering rapid tests is expected to boost the sales of reagents used in molecular biology techniques.
In the next five years, the demand for bioinformatics services from pharmaceutical companies is projected to soar from $2 billion to over $5.7 billion. This growth can be attributed to the development of new drugs and the expanding global patient populations.
Bioinformatics: Paving the Way for Mainstream Research
As technology evolves and new applications emerge, bioinformatics is transitioning from a field primarily focused on specific analysis tasks to one with broader applications in the biological sciences. The ultimate goal is for bioinformatics to become an integral part of mainstream research, leading to groundbreaking discoveries. To achieve this objective, funding agencies like the National Institute of Health (NIH) and the National Science Foundation (NSF) are providing increased support for bioinformatics research, attracting interdisciplinary researchers, and restructuring the field.
Medical bioinformatics, in particular, is poised to dominate the global bioinformatics market. It plays a vital role in various disciplines, including medical, agricultural biotechnology, and animal science, facilitating advancements in plant science, molecular genetics, and genomics. Moreover, medical informatics enables healthcare institutions to harness computer technology for improved patient care, medication management, and public health policy decisions.
North America Continues to Lead the Way
North America remains at the forefront of the global bioinformatics market, with a healthy growth rate projected for the region. The expansion of research and development activities in biotechnology companies is a significant driver of this growth. For instance, Pfizer Inc. is establishing its first innovation hub outside New York City in Cambridge, with a substantial portion of its staff relocating to Europe. However, the increasing biotechnology activities in North America are creating a demand for professionals with specialized skillsets, particularly in the fields of DNA sequencing and genotyping tools.
Opportunities Abound in Developing Regions
Developing regions, especially the Asia-Pacific, are emerging as significant players in the bioinformatics market. The government’s investments in healthcare, pharmaceuticals, and biotechnology have spurred scientific research and increased funding for healthcare, creating new opportunities for bioinformatics software applications. Translational research initiatives such as drug repositioning and functional genomics data interpretation are gaining prominence, driving the need for computer-aided drug discovery technology.
Key Players in the Global Bioinformatics Market
Prominent players in the global bioinformatics market include Eurofins Scientific, Thermo Fisher Scientific, Agilent Technologies, QIAGEN N.V., Illumina, NeoGenomics Laboratories, Perkin Elmer, Waters Corporation, DNASTAR, GENEWIZ, BGI Group, Partek Incorporated, Fios Genomics, SOPHiA Genetics, Biomax Informatics AG, and Source BioScience, among others.
The future of bioinformatics appears bright, with rapid growth expected to continue as it integrates further into mainstream research and supports advancements in various scientific disciplines.
Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 – By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) https://www.fairfieldmarketresearch.com/report/bioinformatics-market
Visit Our Blogs:
https://www.fuzia.com/article_detail/802952/global-redox-flow-battery-market-size-2030
About Us
Fairfield Market Research is a UK-based market research provider. Fairfield offers a wide spectrum of services, ranging from customized reports to consulting solutions. With a strong European footprint, Fairfield operates globally and helps businesses navigate through business cycles, with quick responses and multi-pronged approaches. The company values an eye for insightful take on global matters, ably backed by a team of exceptionally experienced researchers. With a strong repository of syndicated market research reports that are continuously published & updated to ensure the ever-changing needs of customers are met with absolute promptness.
Contact
Fairfield Market Research
London, UK
UK +44 (0)20 30025888
USA (Toll-free) +1 (844) 3829746
Web: https://www.fairfieldmarketresearch.com/
Email: sales@fairfieldmarketresearch.com
This press release first seen on Brilad
